Liraglutide vs semaglutide vs dulaglutide in veterans with type 2 diabetes

JAMA Network Open

2025-10-13

(Press-News.org) About The Study: In this comparative effectiveness study in veterans with diabetes, liraglutide, semaglutide, and dulaglutide initiators had similar risks for kidney and cardiovascular outcomes. Head-to-head randomized trials are needed to confirm these findings.

Corresponding Author: To contact the corresponding author, Srinivasan Beddhu, MD, email srinivasan.beddhu@hsc.utah.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2025.37297)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.37297?guestAccessKey=1b34668e-afe8-4888-aa3d-dd05b3b83eff&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101325

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

Antenatal corticosteroids and infectious diseases throughout childhood

2025-10-13

About The Study: In this cohort study, exposure to antenatal corticosteroids (ACS) was associated with increased risks of infections in full-term children until age 21. In preterm children born before 34 weeks’ gestation, no association between ACS and infections was found. To minimize the adverse effects of ACS treatment, more stringent criteria for ACS administration and better prediction tools for preterm birth are required. Corresponding Author: To contact the corresponding author, Rebecca M. Reynolds, ...

New lab-grown human embryo model produces blood cells

2025-10-13

University of Cambridge scientists have used human stem cells to create three-dimensional embryo-like structures that replicate certain aspects of very early human development - including the production of blood stem cells. Human blood stem cells, also known as hematopoietic stem cells, are immature cells that can develop into any type of blood cell, including red blood cells that carry oxygen and various types of white blood cells crucial to the immune system. The embryo-like structures, which the scientists have named ‘hematoids’, are self-organising and start producing blood after around ...

Life after near death: Research reveals how to improve support for near-death experiencers

2025-10-13

Near-death experiences can have lasting, life-changing effects, and new University of Virginia School of Medicine research sheds light on the types of counseling and support that can best help people cope. The research, from UVA’s Division of Perceptual Studies, is believed to be the first to explore the most common and effective ways to assist people grappling with potentially profound changes to their world view. For most, near-death experiences, or NDEs, have a positive effect; the brush with ...

Illinois Chat is launched for campus community

2025-10-13

What began as a student project in 2023 will now serve a whole university community. Illinois Chat, an official artificial intelligence (AI) software tool of the University of Illinois Urbana-Champaign, has launched for the Fall 2025 semester and is available for anyone on campus. In partnership with the Office of the Chief Information Officer (CIO) and Illinois Computes, NCSA developed Illinois Chat to offer large language model (LLM) abilities to the entire campus community. This campus-developed tool allows users to create personalized LLM-based chatbots – ...

FAU receives $3M federal grant to prevent substance use in at-risk youth

2025-10-13

Florida Atlantic University has received a $3 million, five-year grant from the Substance Abuse and Mental Health Services Administration (SAMHSA), a division of the United States Department of Health and Human Services, to lead a transformative community initiative designed to prevent substance use among South Florida’s youth. The new program, “Rising Strong: Empowering Youth for Substance-Free Futures,” will implement evidence-based, trauma-informed prevention strategies to reach more than 3,000 youth across Palm Beach and Broward counties ...

New report shows action to improve gender equity linked to career gains and better business performance

2025-10-13

A new report out today shows that companies taking action for gender equality see lower staff turnover, more women in leadership and better shareholder value. The 10th report in the Gender Equity Insights Series from Bankwest Curtin Economics Centre (BCEC) and the Workplace Gender Equality Agency (WGEA) also warns Australian businesses could fall behind their competitors if they don’t take strong action to address gender balance. The report investigates what drives gender balance. Gender balance means having at least ...

Kiwis could help manage chronic constipation

2025-10-13

Kiwifruits, rye bread and high mineral-content water could all help alleviate chronic constipation. That’s according to the first ever evidence-based dietary guidelines for adults with chronic constipation, led by researchers at King’s College London. The new guidelines also show that taking psyllium fibre supplements, certain probiotic strains and magnesium oxide supplements can help to improve constipation. In contrast, other widely recommended approaches, including generic “high-fibre diets,” and senna supplements (a type of laxative) were found to lack strong evidence ...

Breast, lung, and bladder cancer phase 3 trials led by Dana-Farber presented at ESMO Congress 2025

2025-10-13

BOSTON, October 12, 2025 – Dana-Farber Cancer Institute researchers are leading four studies with important new findings in breast cancer, lung cancer, and bladder cancer at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The studies will be presented both in-person and online from October 17 to October 21. A full list of Dana-Farber Presentations at ESMO 2025 is available here: Dana-Farber Presentations at ESMO 2025 Dana-Farber investigators will also ...

New open-source software allows for efficient 3D printing with multiple materials

2025-10-13

A new open-source tool is reshaping how engineers design multi-material objects. Charles Wade, a PhD student in the Department of Computer Science at the University of Colorado Boulder, has created a design system software package that uses functions and code to map not just shapes but also where different materials belong in a 3D object. The project, called OpenVCAD, was developed in the Matter Assembly Computation Lab led by Assistant Professor Robert MacCurdy of the Paul M. Rady Department of Mechanical Engineering. A new paper, published October 13 in the journal Additive Manufacturing, highlights the design tool and its potential to ...

Decoding the secrets of ‘chemo brain’

2025-10-13

Cancer is a challenging enough diagnosis, but many patients are dealt a second blow, even as they heal: “chemo brain.” Also called “brain fog,” this mix of cognitive issues — memory problems, struggling to find words, an inability to concentrate — affects up to three-in-four cancer patients, according to multiple studies. For many, the effects last years beyond cancer treatment. A new study offers new models for studying causes of chemo brain and points to the effects of chemotherapy drugs on the brain’s lymphatic system, which ...

Liraglutide vs semaglutide vs dulaglutide in veterans with type 2 diabetes

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: